Corton Capital Inc. Seres Therapeutics, Inc. Transaction History

Corton Capital Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$2.33 - $5.07 $99,087 - $215,611	-42,527 Reduced 64.66%	23,245 $55,000
Q2 2023 Aug 14, 2023	BUY	$4.67 - $6.55 $307,155 - $430,806	65,772 New	65,772 $315,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $219,876 - $308,524	-34,901 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $210,104 - $398,918	34,901 New	34,901 $291,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.